Priapism as first clinical manifestation of chronic myeloid leucosis
- Autores: Rustamov M.N1, Huseynov G.R2, Ahmedov I.S.2
-
Afiliações:
- FGAOU VO I.M. Sechenov First Moscow State Medical University
- Azerbaijan Medical University
- Edição: Nº 5 (2019)
- Páginas: 112-113
- Seção: Articles
- URL: https://journals.eco-vector.com/1728-2985/article/view/312302
- DOI: https://doi.org/10.18565/urology.2019.5.112-113
- ID: 312302
Citar
Texto integral
Acesso aberto
Acesso está concedido
Acesso é pago ou somente para assinantes
Resumo
Blood disorders, in particular chronic myeloid leukemia (CML), are among the rare etiological factors of priapism. A clinical observation of ischemic priapism lasting 18 hours, which developed in patients with previously not diagnosed CML, is presented in the article. The CML was subsequently diagnosed based on the results of blood analyses and bone marrow aspiration. Treatment strategy consisted of immediate aspiration of blood from the cavernous bodies (19G) followed by the intracavernous injection of phenylephrine solution. After resolving priapism, CML therapy was carried out, which allowed to avoid a recurrence of priapism.
Palavras-chave
Texto integral
Sobre autores
M. Rustamov
FGAOU VO I.M. Sechenov First Moscow State Medical University
Email: rustamovmaarif@gmaiI.com
G. Huseynov
Azerbaijan Medical University
Email: drqabilhuseynov@gmail.com
I. Ahmedov
Azerbaijan Medical University
Email: doctor.ilham@hotmail.com
Bibliografia
- Eland I.A., van der Lei J., Strieker B.H. et al. Incidence of priapism in the general population. Urology 2001; 57(5):970-972.
- Metawea B., El-Nashar A.R., Gad-Allah A., Abdul-Wahab M. et al. Intracavernous papaverine/phentolamine-induced priapism can be accurately predicted with color Doppler ultrasonography. Urology. 2005;66(4):858-860.
- Keoghane S.R., Sullivan M.E., Miller M.A.W The aetiology, pathogenesis and management of priapism. BJU International. 2002;90(2):149-154.
- Broderick G.A., Kadioglu A., Bivalacqua T.J., Ghanem H. et al. Priapism: pathogenesis, epidemiology, and management. J Sex Med. 2010;7(1 Pt 2):476-500.
- Huei T.J., Henry Tan Chor Lip, Shamsuddin Omar. A rare presentation of chronic myeloid leukaemia with priapism treated with corporoglandular shunting. Med J Malaysia. 2018;73(6):420-422.
- Dhar J., Dhar J., Chhabra G., Khandelwal L., Khandelwal L., Batra A., Gupta N., Gupta N. Priapism as a Debut Presentation of Chronic Myeloid Leukemia. J Coll Physicians Surg Pak. 2019;29(1):78-80. Doi:10.29271/ jcpsp.2019.01.78
- Kumar P., Rahman K., Kumari S., Singh M.K., Gupta R., Nityanand S. Priapism as a rare presentation of chronic myeloid leukemia. J Cancer Res Ther. 2018;14(6):1442-1443. doi: 10.4103/0973-1482.199388
- Khan A., Shafiq I., Shah M.H., Khan S., Shahid G., Arabdin M. Chronic myeloid leukaemia presenting as priapism: A case report from Khyber Pakhtunkhwa. J Pak Med Assoc. 2018;68(6):942-944.
- Becerra-Pedraza L.C. et al. International Journal of Surgery Case Reports. 2018;43:13-17.
- Montague D.K., Jarow J., Broderick G.A. et al. American Urological Association guideline on the management of priapism. J Urol. 2003;170:1318e1324. doi: 10.1097/01.ju.0000087608.07371.ca.
- Ergenc H., Varim C., Karacaer C., Qekdemir D. Chronic myeloid leukemia presented with priapism: Effective management with prompt leukapheresis. Niger J Clin Pract 2015;18(6):828-30. doi: 10.4103/11193077.163282.
Arquivos suplementares
